CapMallsAsia - MISCELLANEOUS
Announcement Type: MISCELLANEOUS
Company: CAPITAMALLS ASIA LIMITED
Stock Code/Name: JS8 - CapMallsAsia
Company: CAPITAMALLS ASIA LIMITED
Stock Code/Name: JS8 - CapMallsAsia
MISCELLANEOUS |
* Asterisks denote mandatory information |
Name of Announcer * | CAPITAMALLS ASIA LIMITED |
Company Registration No. | 200413169H |
Announcement submitted on behalf of | CAPITAMALLS ASIA LIMITED |
Announcement is submitted with respect to * | CAPITAMALLS ASIA LIMITED |
Announcement is submitted by * | Choo Wei-Pin |
Designation * | Company Secretary |
Date & Time of Broadcast | 21-Nov-2012 21:19:23 |
Announcement No. | 00085 |
>> ANNOUNCEMENT DETAILS |
The details of the announcement start here ... |
Announcement Title * | CAPITAMALL TRUST - "PRIVATE PLACEMENT OF NEW UNITS IN CMT AT AN ISSUE PRICE OF BETWEEN S$1.99 AND S$2.07 PER NEW UNIT" |
Description |
|
Attachments |
Total size = 134K (2048K size limit recommended) |
Religare - DISCLOSURE OF INTEREST/CHANGES IN INTEREST OF SUBSTANTIAL SHAREHOLDER(S)/UNITHOLDER(S)
Announcement Type: DISCLOSURE OF INTEREST/CHANGES IN INTEREST
Company: RELIGARE HEALTH TRUST
Stock Code/Name: RF1U - Religare
Company: RELIGARE HEALTH TRUST
Stock Code/Name: RF1U - Religare
DISCLOSURE OF INTEREST/CHANGES IN INTEREST OF SUBSTANTIAL SHAREHOLDER(S)/UNITHOLDER(S) |
* Asterisks denote mandatory information |
Name of Announcer * | RELIGARE HEALTH TRUST |
Company Registration No. | N.A. |
Announcement submitted on behalf of | RELIGARE HEALTH TRUST |
Announcement is submitted with respect to * | RELIGARE HEALTH TRUST |
Announcement is submitted by * | Ravi Mehrotra |
Designation * | Executive Chairman and Cheif Executive Officer |
Date & Time of Broadcast | 21-Nov-2012 20:27:45 |
Announcement No. | 00081 |
>> ANNOUNCEMENT DETAILS |
The details of the announcement start here ... |
Person(s) giving notice * | Substantial Shareholder(s)/Unitholder(s) (Form 3) |
Date of receipt of notice by Listed Issuer * | 20-11-2012 |
Attachments |
Total size = 113K (2048K size limit recommended) |
No comments:
Post a Comment